Cancer Biology and Medicine : Impact Factor & More
eISSN: 2095-3941pISSN: 2095-3941
Open AccessShare this on:
Key Metrics
CiteScore 
6.5
SNIP
1.13
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cancer Biology and Medicine
Cancer Biology and Medicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | CHINA ANTI-CANCER ASSOC |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | USD 1500 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Cancer Biology and Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cancer Biology and Medicine
FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells.
- 28 Jul 2026
- Cancer biology & medicine
Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis.
- 27 Jul 2026
- Cancer biology & medicine
From chemical compounds to herbal interventions: a transfer learning-based perturbational transcriptome prediction framework for cancer drug discovery.
- 22 Jul 2026
- Cancer biology & medicine
Harnessing the microbiome: a new frontier in lung cancer immunotherapy.
- 20 Jul 2026
- Cancer biology & medicine
Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer.
- 20 Jul 2026
- Cancer biology & medicine
Next-generation CAR immunotherapy for neuroblastoma: expanding the role of immune cell platforms.
- 20 Jul 2026
- Cancer biology & medicine
FDX1 expression promotes DSF/Cu-induced cuproptosis in gastric cancer cells.
- 28 Jul 2026
- Cancer biology & medicine
Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis.
- 27 Jul 2026
- Cancer biology & medicine
From chemical compounds to herbal interventions: a transfer learning-based perturbational transcriptome prediction framework for cancer drug discovery.
- 22 Jul 2026
- Cancer biology & medicine
Harnessing the microbiome: a new frontier in lung cancer immunotherapy.
- 20 Jul 2026
- Cancer biology & medicine
Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer.
- 20 Jul 2026
- Cancer biology & medicine
Next-generation CAR immunotherapy for neuroblastoma: expanding the role of immune cell platforms.
- 20 Jul 2026
- Cancer biology & medicine
FAQs on Cancer Biology and Medicine
How long has Cancer Biology and Medicine been actively publishing? 
What is the publishing frequency of Cancer Biology and Medicine?
How many articles did Cancer Biology and Medicine publish last year?
What is the eISSN & pISSN for Cancer Biology and Medicine?
What is Citescore for Cancer Biology and Medicine?
What is SNIP score for Cancer Biology and Medicine?
Who is the publisher of Cancer Biology and Medicine?
